Research in Social & Administrative Pharmacy最新文献

{"title":"Impact of pharmacist-led antibiotic stewardship audit-feedback intervention; systematic review and meta-analysis.","authors":"Duaa Salem Jawhar, Amer Hayat Khan, Khurshid Alam, Rabbiya Ahmad","doi":"10.1016/j.sapharm.2025.11.002","DOIUrl":"https://doi.org/10.1016/j.sapharm.2025.11.002","url":null,"abstract":"<p><strong>Background: </strong>The escalating threat of antimicrobial resistance continues to burden healthcare systems globally. Antimicrobial stewardship programs (ASPs) are recognized as a cornerstone strategy to mitigate inappropriate antibiotic use and curb resistance. Despite their growing implementation, the impact of pharmacist-led audit and feedback interventions within ASPs remains insufficiently explored.</p><p><strong>Objective: </strong>To synthesize the evidence on the effect of pharmacist-led audit-feedback interventions within ASPs.</p><p><strong>Methods: </strong>In accordance with PRISMA guidelines, the pooled estimate of pharmacist-led ASP audit-feedback interventions was calculated using a random-effects model. The Cochrane risk of bias tools were employed to assess the quality of the studies. We searched PubMed, SCOPUS, EBSCO/CINAHL, and Web of Science from January 1, 2000, to June 30, 2024. We included randomized controlled trials, cohort studies, case-control studies, and quasi-experimental studies. Sensitivity analyses were conducted using the leave-one-out method. Publication bias was assessed through funnel plot and Egger's regression test. Study protocol registered with PROSPERO (CRD420251036088).</p><p><strong>Results: </strong>A total of 69,666 studies were screened, with 14 ultimately included in the final qualitative and quantitative analysis. Including 17805 patients in the pooled analysis. Pharmacist-led ASP audit-feedback intervention associated with reduction in antibiotic days of therapy, length of hospital stay (MD = -5.93, 95 % CI -12.90-1.03, I² 97.7 %), significant increase in appropriate antibiotic prescribing practice (OR 2.72, 95 % CI 1.51-4.88, I² 75 %) and 25 % reduction in mortality (OR 0.75, 95 % CI 0.55-1.03, I² 88 %) CONCLUSION: This systematic review and meta-analysis provide growing evidence that pharmacist-led audit and feedback interventions within ASPs are associated with a significant improvement in appropriate antibiotic prescribing and reduction in mortality, length of hospital stay, and days of therapy. These findings support the integration of pharmacists as key leaders in ASPs and highlight the potential for policymakers to prioritize investment in pharmacist-led stewardship roles.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145745209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From pill to purpose: Rethinking outcomes evaluation through patient-centered metrics in pharmacoepidemiology and chronic disease management","authors":"Mohamed AbdElrahman ,&nbsp;Mohammed D. Al-Rekabi ,&nbsp;Mohamed E.A. Abdelrahim","doi":"10.1016/j.sapharm.2025.11.001","DOIUrl":"10.1016/j.sapharm.2025.11.001","url":null,"abstract":"<div><div>Despite progress in medication and evidence-based protocols, a disparity persists between clinical outcomes and patients lived experiences. Conventional pharmacoepidemiologic metrics—such as biomarker targets or hospitalization rates—frequently do not capture what patients prioritize: functionality, autonomy, and quality of life. This article promotes a transition to patient-centered measures, such as patient-reported outcomes (PROs), goal attainment scaling (GAS), and behavioral adherence models. By incorporating these approaches into research and practice, healthcare systems can more effectively assess therapy efficacy in real-world settings. The opinion emphasizes data that supports Patient-Reported Outcomes (PROs) and Goal Attainment Scaling (GAS), addresses implementation problems, and advocates for the realignment of assessment systems towards purpose-driven care. Ultimately, aligning outcome evaluation with patients' objectives promotes relevance, equity, and participation in chronic disease management—prompting pharmacoepidemiology to evaluate not only the efficacy of pharmaceuticals but also their meaningful impact on the lives of users.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 354-356"},"PeriodicalIF":2.8,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A survey of open science attitudes and behaviors among US pharmacy faculty","authors":"Spencer E. Harpe","doi":"10.1016/j.sapharm.2025.10.012","DOIUrl":"10.1016/j.sapharm.2025.10.012","url":null,"abstract":"<div><h3>Objectives</h3><div>To describe the attitudes, behaviors, and perceived disciplinary norms for open science practices among US pharmacy faculty and examine differences across pharmacy disciplines.</div></div><div><h3>Methods</h3><div>This cross-sectional study used the Center for Open Science's Open Scholarship Survey modules on data sharing, code sharing, materials sharing, preregistration, preprints, and open access publishing. Attitudes were measured using a scale from 1 (Very much against) to 5 (Very much in favor). The study questionnaire was administered to a random sample of 3200 faculty from the AACP Roster of Pharmacy Faculty as of February 2022. Individuals with ≥0.8 full-time equivalent faculty appointment in pharmacy practice or one of the pharmaceutical sciences were eligible to participate.</div></div><div><h3>Results</h3><div>Responses were obtained from 663 faculty (389 complete; 274 partial). Open access publishing (mean [SD]: 4.1 [0.9]) showed the most positive attitudes. Study preregistration (3.2 [0.9]) and posting preprints (3.1 [1.1]) were the least positive. Attitudes for data sharing, code sharing, and study preregistration were statistically significant across disciplines. The most commonly reported open science practice was open access publishing (mean [SD], 27.7 % [29.1 %]). Study preregistration was the least common (mean [SD], 1.7 % [7.0 %]). After accounting for respondent and institutional characteristics, disciplinary differences in data sharing, study preregistration, and posting preprints were noted.</div></div><div><h3>Conclusion</h3><div>This study provides a baseline assessment of attitudes towards and engagement in open science practices among US pharmacy faculty. Given the relatively low frequency with which open science practices were reported, there is considerable room for improvement in the uptake of open science practices.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 317-325"},"PeriodicalIF":2.8,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Racial and socioeconomic disparities in the utilization of diabetes medication: A comprehensive analysis of NHANES 2011–2023","authors":"Rawan O. Almadfaa","doi":"10.1016/j.sapharm.2025.10.013","DOIUrl":"10.1016/j.sapharm.2025.10.013","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the association between racial and socioeconomic health disparities and diabetes medications utilization using a nationally representative sample of the US population.</div></div><div><h3>Method</h3><div>This study included 4469 diabetic patients (weighted N = 23,678,032) aged ≥20 years from the National Health and Nutrition Examination Survey (NHANES) 2011–2023. Patients were classified into four groups based on medication use: insulin only, noninsulin glucose-lowering drugs (GLDs), both, or none. Univariate, bivariate, and multinomial logistic regression analyses were performed to assess associations between medication use and health disparities. All analyses were weighted for the survey's complex, multistage design of NHANES.</div></div><div><h3>Results</h3><div>Among the 4469 patients, 579 used insulin, 2411 used noninsulin GLDs, 754 used both, and 725 were untreated. Older patients had higher odds of using non-insulin GLDs (OR = 1.018, 95 % CI: 1.009–1.027) and both therapies (OR = 1.012, 95 % CI: 1.001–1.022) compared with younger adults. Males were more likely to use diabetes medications than females. Asians had higher odds of medication use, while other racial groups had lower odds than Whites. Participants with income higher income had lower odds of using both insulin and non-insulin GLDs (OR = 0.708, 95 % CI: 0.521–0.964) compared with those with lower income. Insured patients were more likely to use medications than the uninsured. Education level and marital status were not significantly associated with diabetes medication utilization.</div></div><div><h3>Conclusion</h3><div>This study identified demographic and socioeconomic differences in diabetes medication utilization among U.S. adults. Lower odds of medication use were observed among Mexican American, other Hispanic, other race group, females, and uninsured participants, as well as those with higher income, indicating potential gaps in equitable diabetes management. Targeted interventions to improve medication access and adherence among these groups are needed to promote more equitable diabetes care in the U.S.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 326-332"},"PeriodicalIF":2.8,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A multisite pilot type 2 hybrid implementation-effectiveness trial of a community pharmacist-led model of collaborative care for Medication Assisted Treatment for Opioid Dependence: outcomes of the EPIC-MATOD trial","authors":"Suzanne Nielsen ,&nbsp;Francis Graham ,&nbsp;Mohammad Hossein Hadi ,&nbsp;Elizabeth Grist ,&nbsp;Bosco Rowland ,&nbsp;John Jackson ,&nbsp;Sarah Lord ,&nbsp;Jana Dostal ,&nbsp;Pene Wood ,&nbsp;Kirsty Morgan ,&nbsp;Dennis Petrie ,&nbsp;Ali Cheetham","doi":"10.1016/j.sapharm.2025.10.009","DOIUrl":"10.1016/j.sapharm.2025.10.009","url":null,"abstract":"<div><h3>Background</h3><div>Australia faces a critical challenge with access to opioid dependence treatment, particularly in regional areas where treatment shortages are amplified.</div></div><div><h3>Objective</h3><div>(s): To assess outcomes of a collaborative care model for opioid dependence treatment where community pharmacists work to their full scope of practice, in partnership with prescribers.</div></div><div><h3>Methods</h3><div>Community pharmacists and prescribers were recruited from the south-eastern suburbs of Melbourne, Victoria, Australia, to take part in a prospective, multisite, Type 2 hybrid implementation-effectiveness trial. Patients received collaborative prescriber/pharmacist care over a 6-month period, with outcomes compared to a non-randomised comparison group receiving usual care. Data was collected using a mixed methods approach with outcomes mapped to the RE-AIM framework. A health economics evaluation established time and costs associated with collaborative care.</div></div><div><h3>Results</h3><div>Collaborative care provided comparable outcomes on retention in treatment (97.2 %, 35/36) compared to the control cohort (89.8 %, 44/49) with no significant differences between groups on substance use or mental or physical health outcomes. Collaborative care was associated with significant increases in treatment satisfaction and quality adjusted life years (QALYs) and was cost-effective when compared to treatment as usual. The model was implemented with relatively high fidelity, with high levels of satisfaction among pharmacists, prescribers, and patients. Considerations for broader implementation included pharmacist workload, the need for secure communication software, and a mechanism to remunerate pharmacists for their time providing clinical care.</div></div><div><h3>Conclusion</h3><div>Pharmacist-led collaborative care for opioid dependence is feasible and acceptable and can provide an at least equivalent standard of care to usual care. Further research is required to establish how collaborative care can maximise prescriber capacity at scale.</div></div><div><h3>Clinical Trial registration</h3><div>ACTRN12621000871842.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 292-310"},"PeriodicalIF":2.8,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145574774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Causes and management of drug shortages: A scoping review","authors":"N. Cornelissen ,&nbsp;S.W. Zielhuis ,&nbsp;P.M.L.A. van den Bemt ,&nbsp;B.J.F. van den Bemt","doi":"10.1016/j.sapharm.2025.10.008","DOIUrl":"10.1016/j.sapharm.2025.10.008","url":null,"abstract":"<div><h3>Background</h3><div>Drug shortages form a significant global challenge and may lead to treatment delays, increased healthcare costs, and negative health outcomes. Gaining more insight into the causes is crucial to develop interventions to prevent shortages and manage their consequences. This scoping review aims to provide an overview of the causes and management of drug shortages in high-income countries.</div></div><div><h3>Methods</h3><div>This scoping review was conducted in accordance with the JBI methodology. A comprehensive search was performed in PubMed, EMBASE, Web of Science, and CENTRAL on December 21, 2023. Studies published in English or Dutch on the causes and management of drug shortages in high-income countries were included. Two reviewers independently screened titles/abstracts and full texts. Relevant data on study characteristics, causes, and interventions were extracted using a standardized form. Findings were analysed descriptively.</div></div><div><h3>Results</h3><div>Thirty-six studies were included out of 4531 citations. Causes of drug shortages included manufacturing issues, fluctuating demand and market forces, poor supply chain management, political and strategic decisions, and external influences. Several studies emphasized that causes were frequently unknown. Interventions to manage shortages focused on alternatives and substitutions, inventory management, communication and coordination, regulatory and policy measures, and forecasting. While causes are primarily linked to early stages of the product life cycle, most interventions occur at later stages and tend to be reactive.</div></div><div><h3>Conclusions</h3><div>Most current interventions focus on temporary solutions at the end of the supply chain, while shortages often originate earlier. A focus on early-stage causes is needed for more effective, preventive solutions.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 232-253"},"PeriodicalIF":2.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Academic community pharmacy: A pilot Delphi study aimed at establishing a future common definition at the international level","authors":"Clémence Perraudin ,&nbsp;Noelia Amador-Fernandez ,&nbsp;Marie Paule Schneider ,&nbsp;Florent Macé ,&nbsp;Ralitza Gauthier ,&nbsp;Alice Panchaud ,&nbsp;Samuel Allemann ,&nbsp;Stefan Erni ,&nbsp;Jérôme Berger","doi":"10.1016/j.sapharm.2025.10.011","DOIUrl":"10.1016/j.sapharm.2025.10.011","url":null,"abstract":"<div><h3>Introduction</h3><div>The Granada statements promote the consistent use of appropriate terminology in pharmacy practice research. This pilot study aims to define the term <em>Academic Community Pharmacy</em> (ACP), providing a foundation for a forthcoming international study aimed at establishing a globally accepted definition.</div></div><div><h3>Methodology</h3><div>A Delphi study was conducted in 2023 among academic entities from all five Swiss universities involved in pharmacy practice research and education. The first definition comprised four kex elements: place of practice, clinical and academic activities and links with universities. Anonymous survey rounds were conducted where panellists assessed agreement with and clarity of the statements using a Likert scale. Additionally, free comments and proposals for changes were allowed. Consensus for each statement was defined as ≥66 % agreement.</div></div><div><h3>Results</h3><div>The panel consisted of nine members. Two Delphi rounds were needed to reach consensus for the final definition: “An ACP is a facility providing professional pharmacy services (according to a commonly accepted definition in the location of the considered ACP) to the community, conducting research and education on such services, and that has formal links (e.g., financial or contractual) with a university”.</div></div><div><h3>Conclusion</h3><div>Establishing a clear and consistent definition of ACPs will support their characterization and further development.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 357-361"},"PeriodicalIF":2.8,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"PharmaCenter: Impact of post-discharge pharmaceutical carea consultation on medication-related problems in the emergenc department: A comprehensive analysis","authors":"Beatriz Torroba-Sanz ,&nbsp;Ana De Lorenzo-Pinto ,&nbsp;Álvaro Giménez-Manzorro ,&nbsp;Carmen Redondo-Galán ,&nbsp;Daniel Gómez-Costas ,&nbsp;Juana Benedí ,&nbsp;Ana Herranz-Alonso ,&nbsp;Maria Sanjurjo-Sáez","doi":"10.1016/j.sapharm.2025.10.010","DOIUrl":"10.1016/j.sapharm.2025.10.010","url":null,"abstract":"<div><h3>Background</h3><div>Transitions of care, particularly after discharge from hospital emergency services, are critical periods associated with a high risk of medication-related problems. These often arise from communication failures and incomplete pharmacotherapeutic information. PharmaCenter was established as a pharmacist-led consultation service designed to manage pharmacotherapeutic queries arising after hospital discharge.</div></div><div><h3>Objective</h3><div>To describe the implementation of PharmaCenter and evaluate its clinical performance. Secondary objectives included assessing its capacity to resolve medication-related problems, analyzing service accessibility and usability, and evaluating patient satisfaction.</div></div><div><h3>Methods</h3><div>A retrospective observational study was conducted over two years in a tertiary teaching hospital. The service was available 24 h a day, seven days a week, providing patients discharged from three emergency departments with access to consultation by telephone or email. Each query was analyzed in terms of origin, time to consultation, time to resolution, and need for physician involvement. A structured survey was used to assess patient satisfaction.</div></div><div><h3>Results</h3><div>Over the study period, 1485 patients used the service, generating 1626 consultations. Most queries originated from adult emergency care. The median time from discharge to consultation was 2.33 days, and the mean resolution time was 1.36 h. In 54.1 percent of cases, pharmacists provided a complete response without physician input. The most frequent issue was failure to prescribe medications in the electronic prescribing system. Among respondents to the satisfaction survey, 93.9 percent indicated the service helped avoid a return to a healthcare facility.</div></div><div><h3>Conclusions</h3><div>PharmaCenter effectively addressed post-discharge medication-related problems and demonstrated high levels of patient satisfaction, offering a scalable model to support safer transitions of care.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 311-316"},"PeriodicalIF":2.8,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145369087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials","authors":"Emre Kara ,&nbsp;Betul Okuyan ,&nbsp;Cansu Goncuoglu ,&nbsp;Kutay Demirkan ,&nbsp;Shusen Sun","doi":"10.1016/j.sapharm.2025.10.007","DOIUrl":"10.1016/j.sapharm.2025.10.007","url":null,"abstract":"<div><h3>Background</h3><div>The role of pharmacists in emergency departments (EDs) has undergone a significant transformation globally, expanding beyond traditional responsibilities to include various clinical activities that promise to enhance patient outcomes. However, the full potential of these interventions, particularly from economic, clinical, and humanistic (ECHO) perspectives, remains to be systematically explored. The aim of this study was to evaluate the impact of pharmacist-led interventions on ECHO among patients admitted to the ED.</div></div><div><h3>Methods</h3><div>This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were conducted in PubMed, MEDLINE, and International Pharmaceutical Abstracts, focusing on randomized controlled trials (RCTs) published in English that involved pharmacist interventions in EDs. Data were extracted on study design, pharmacist interventions, and patient outcomes. Cochrane risk-of-bias tool for randomized trials (RoB 2.0) was used.</div></div><div><h3>Results</h3><div>Twelve RCTs that met the inclusion criteria were identified. The studies were conducted predominantly in tertiary care settings in various countries. The most common interventions performed by pharmacists included medication reconciliation, obtaining medication histories, and patient education. The review showed that pharmacist interventions tend to improve medication safety and patient satisfaction but varied significantly in their execution and reported outcomes. No studies comprehensively analyzed economic outcomes, and only a few addressed humanistic outcomes.</div></div><div><h3>Conclusions</h3><div>Pharmacy-led services improved clinical outcomes, however there was lack of studies showing the economic and humanistic outcomes of these services. The need for standardized protocols and further research to establish their broader impacts should be considered. The findings support the continued integration and expansion of pharmacist roles in emergency care, which could influence global policy and practice in healthcare systems.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 222-231"},"PeriodicalIF":2.8,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145929303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of the Aged Care On-site Pharmacist (ACOP) program in Australian residential aged care homes: Key considerations and next steps","authors":"Janet K. Sluggett ,&nbsp;Daria S. Gutteridge ,&nbsp;Annabel Calder ,&nbsp;Georgina A. Hughes ,&nbsp;Elizabeth Manias ,&nbsp;Shanthi A. Ramanathan ,&nbsp;Kurtis Budden ,&nbsp;Ingrid Sketris ,&nbsp;Sara Javanparast","doi":"10.1016/j.sapharm.2025.10.006","DOIUrl":"10.1016/j.sapharm.2025.10.006","url":null,"abstract":"<div><div>Older people who live in residential aged care homes (RACHs) often experience polypharmacy and use potentially inappropriate medications. In response to issues identified by a recent national inquiry that identified the need to improve medication management practices in Australian RACHs, a federal government-subsidized initiative to enable clinical pharmacists to practice on-site in Australian RACHs has recently been launched. This new optional program has been funded to enhance quality use of medicines and resident's health and wellbeing in Australian RACHs. This commentary discusses the need for a comprehensive evaluation of this population-based and publicly subsidized initiative to improve medication management in RACHs. It presents a program logic model that outlines the required activities, key outputs and anticipated impacts of Australia's RACH on-site pharmacist program to aid program implementers and beneficiaries to plan, communicate, and evaluate this new program. The program logic model presented can also inform the actions of policy makers and program implementers in other countries who are involved in planning, execution and evaluation of new pharmacist-led interventions or programs in RACHs.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 348-353"},"PeriodicalIF":2.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145929328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}